Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

Angulo, 1998, Management of primary biliary cirrhosis and autoimmune cholangitis, Clin Liver Dis, 2, 333, 10.1016/S1089-3261(05)70011-8 Poupon, 1991, A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis, N Engl J Med, 324, 1548, 10.1056/NEJM199105303242204 Poupon, 1994, Ursodiol for the long-term treatment of primary biliary cirrhosis, N Engl J Med, 330, 1342, 10.1056/NEJM199405123301903 Lindor, 1994, Ursodeoxycholic acid in the treatment of primary biliary cirrhosis, Gastroenterology, 106, 1284, 10.1016/0016-5085(94)90021-3 Lindor, 1996, Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis, Gastroenterology, 1110, 1515, 10.1053/gast.1996.v110.pm8613058 Heathcote, 1994, The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis, Hepatology, 19, 1149, 10.1002/hep.1840190512 Poupon, 1997, Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis, Gastroenterology, 113, 884, 10.1016/S0016-5085(97)70183-5 Pasha, 1998, Cost-effectiveness of ursodeoxycholic acid in primary biliary cirrhosis, Hepatology, 29, 21, 10.1002/hep.510290116 Tint, 1982, Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones, Ann Intern Med, 97, 351, 10.7326/0003-4819-97-3-351 Nakagawa, 1990, Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration, Hepatology, 12, 322, 10.1002/hep.1840120221 Osuga, 1989, Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis, Dig Dis Sci, 34, 49S, 10.1007/BF01536663 Combes, 1995, A randomized, double-blind, placebocontrolled trial of ursodeoxycholic acid in primary biliary cirrhosis, Hepatology, 22, 759 Jorgensen, 1995, Characterization of patients with a complete biochemical response to ursodeoxycholic acid, Gut, 36, 935, 10.1136/gut.36.6.935 Lacerda, 1993, Ursodiol therapy in primary biliary cirrhosis (PBC): enrichment correlates with biochemical improvement, Gastroenterology, 104, A933 van de Meeberg, 1996, Single or multiple dose of ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response, J Hepatol, 25, 887, 10.1016/S0168-8278(96)80293-5 Podda, 1989, Effect of different doses of ursodeoxycholic acid in chronic liver disease, Dig Dis Sci, 34, 59S, 10.1007/BF01536665 Poupon, 1987, Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?, Lancet, i, 834, 10.1016/S0140-6736(87)91610-2 Leuschner, 1989, Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial, Gastroenterology, 97, 1268, 10.1016/0016-5085(89)91698-3 Dickson, 1989, Prognosis in primary biliary cirrhosis: model for decision making, Hepatology, 10, 1, 10.1002/hep.1840100102 Ludwig, 1978, Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis), Virchows Arch [A], 379, 103, 10.1007/BF00432479 Rossi, 1987, High pressure liquid chromatographic analysis of conjugate bile acids in humans bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids, J Lipid Res, 28, 589, 10.1016/S0022-2275(20)38684-3 Pasha, 1996, Early predictors of treatment failure in patients treated with ursodeoxycholic acid for primary biliary cirrhosis, Gastroenterology, 110, A129 Poupon, 1997, Prognostic factors in ursodeoxycholic acid treated patients with primary biliary cirrhosis, Hepatology, 26, 400A Kilmurry, 1996, Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?, Hepatology, 23, 1148 Colombo, 1992, Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease, Hepatology, 15, 677, 10.1002/hep.1840150421 Jazrawi, 1994, Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid, Gastroenterology, 106, 134, 10.1016/S0016-5085(94)94899-2 Lindor, 1998, Relationship between biliary and serum bile acids and response to ursodeoxvcholic acid in patients with primary biliary cirrhosis, Am J Gastroenterol, 93, 1498, 10.1111/j.1572-0241.1998.00470.x Emond, 1996, Does ursodeoxycholic acid improve survival in patients with primary biliary cirrhosis? Comparison of outcome in the U.S. multicenter trial to expected survival using the Mayo Clinic prognostic model, Hepatology, 24, 168A